Stem cell factor receptor/c-Kit: from basic science to clinical implications.

Area of Science:

• Molecular Biology
• Cell Signaling
• Pharmacology

Background:

• Stem cell factor (SCF) binds and activates the c-Kit receptor tyrosine kinase, initiating intracellular signaling cascades.
• c-Kit signaling regulates vital cellular processes including survival, migration, proliferation, hematopoiesis, pigmentation, and fertility.

Purpose of the Study:

• To review the structural and functional aspects of c-Kit signaling in normal physiology.
• To summarize the role of c-Kit signaling in pathological conditions, particularly cancer and allergy.
• To highlight advances in developing small molecule inhibitors targeting c-Kit function.

Main Methods:

• Literature review of studies on c-Kit structure, function, and signaling pathways.
• Analysis of research on gain-of-function and loss-of-function mutations in c-Kit.
• Examination of therapeutic strategies targeting c-Kit, including approved and investigational inhibitors.

Main Results:

• c-Kit activation involves autophosphorylation and recruitment of signaling proteins via specific interaction domains.
• Aberrant c-Kit activity, due to mutations, drives tumor formation and progression, making it a therapeutic target.
• Loss-of-function mutations in c-Kit are associated with conditions like piebaldism.

Conclusions:

• c-Kit signaling is a critical pathway with diverse physiological roles, and its dysregulation contributes to significant pathologies.
• Targeted inhibition of c-Kit, exemplified by imatinib, sorafenib, and sunitinib, represents a key therapeutic approach for c-Kit-driven diseases.
• Continued research into c-Kit structure-function relationships and inhibitor development holds promise for future therapeutic advancements.